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Background: Caesarean section (CS) has short and long-term health effects for both the woman and her baby.
One of the greatest contributors to the CS rate is elective repeat CS. Vaginal birth after caesarean (VBAC) is an
option for many women; despite this the proportion of women attempting VBAC remains low. Potentially the
relationship that women have with their healthcare professional may have a major influence on the uptake of
VBAC. Models of service delivery, which enable an individual approach to care, may make a difference to the
uptake of VBAC. Midwifery continuity of care could be an effective model to encourage and support women to
choose VBAC.
Methods/Design: A randomised, controlled trial will be undertaken. Eligible pregnant women, whose most recent
previous birth was by lower-segment CS, will be randomly allocated 1:1 to an intervention group or control group.
The intervention provides midwifery continuity of care to women through pregnancy, labour, birth and early
postnatal care. The control group will receive standard hospital care from different midwives through pregnancy,
labour, birth and early postnatal care. Both groups will receive an obstetric consultation during pregnancy and at
any other time if required. Clinical care will follow the same guidelines in both groups.
Discussion: This study will determine whether midwifery continuity of care influences the decision to attempt a
VBAC and impacts on mode of birth, maternal experiences with care and the health of the neonate. Outcomes
from this study might influence the way maternity care is provided to this group of women and thus impact on
the CS rate. This information will provide high level evidence to policy makers, health service managers and
practitioners who are working towards addressing the increased rate of CS.
Trial registration: This trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR):
ACTRN12611001214921
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The rate of caesarean section (CS) in Australia has in-
creased over the past decade and is now well above many
similar countries [1,2]. One of the greatest contributors to
the overall CS rate is a woman having an elective repeat
CS (ERCS) [1]. In one Australian state, 76% of those with
a previous CS who give birth at term have another CS,* Correspondence: caroline.homer@uts.edu.au
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reproduction in any medium, provided the orand one third of all CS involves women who have had a
previous CS [1]. A National Review of Maternity Services
undertaken in Australia highlighted concerns around the
high rates of caesarean section and recommended that the
Australian government “initiate targeted research aimed at
improving the quality and safety of maternity services in
select key priority areas, such as evidence around inter-
ventions, particularly caesarean sections” (page 14) [2].
Concerns about a high CS rate centre around growing
evidence of increasing maternal morbidity associated with
such operations for women, such as increased blood loss,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and longer hospital stays [3-6]. Repeat CS has also been
associated with significantly higher maternal and neonatal
morbidity and mortality compared with caesarean or vagi-
nal births for women who do not have a prior CS [5,7-10].
Babies born by CS are at risk of respiratory distress
syndrome [11], persistent pulmonary hypertension and
admission to a neonatal intensive care unit [12,13].
Neonatal mortality rates have been reported to be 1.7 to
1.9 times higher amongst babies born by CS compared
with those born vaginally [14]. Previous CS has also been
associated with an increased risk of stillbirth [15].
As an alternative, women who have had a previous
lower-segment CS, and an uncomplicated pregnancy, can
be offered to attempt a vaginal birth after CS (VBAC) [16].
However, a cross-sectional study undertaken in one
Australian state (New South Wales) showed that, despite
this, the rate of VBAC declined significantly between 1998
and 2006 (from 31% to 19%, respectively) and the propor-
tion of women who attempted a vaginal birth also declined
(from 49% to 35%, respectively) [17]. In this study, more
than half the women (59%) who attempted VBAC were
successful [17].
The best available international evidence suggests that
VBAC does not increase the risk of hysterectomy or
maternal mortality [18]. Neonatal mortality rate, after
adjustments are made for pre-existing fetal anomalies,
has been reported to be 24 per 10,000 for women who
planned a VBAC compared with 9 per 10,000 for those
who planned a repeat CS [18]. Although this results in an
increased risk, the absolute risk is small, and comparable
to the background risk of neonatal mortality for women
having their first baby [19]. In the USA, a large prospective
observational study involving nearly 46,000 women showed
that planned VBAC was associated with a 1% increased
risk of a blood transfusion, a 1% increased risk of endo-
metriosis, and a 0.7% risk of symptomatic uterine rup-
ture. Rates of uterine rupture for women who undergo
a planned VBAC have been reported to be in the range of
22–74 per 10,000, compared with a risk of 0.5–2 per10,000
births in women with non-scarred uteri [1,19]. Other evi-
dence shows a lesser increase in risk of perinatal mortality
for VBAC, with a risk difference of 1.5 per 10,000 births
compared with repeat caesarean section [20]. Therefore
offering women the opportunity to attempt VBAC, in an
appropriately staffed and resourced maternity unit, is a safe
and ethical innovation to test.
Whereas no studies have examined the effects of mid-
wifery continuity of care, some research has examined
what influences women to choose VBAC. One study
from the USA showed that the major influences were
the woman’s sense of control in the decision-making
process and the clinician’s encouragement of VBAC [21].
Whereas these were not linked to a model of care, it iswell established that midwifery continuity of care programs
increase women’s sense of control over decision mak-
ing, [22] hence the logical link in our hypothesis. Two
randomised controlled trials evaluating different antenatal
education interventions designed to increase VBAC rates
have been published and neither intervention altered VBAC
rates [23,24]. One of the studies showed that consistent in-
formation using a decision-aid booklet reduced decisional
conflict [25]. We plan to build on this evidence by providing
consistent antenatal information from a small group of mid-
wives, together with continuity of care in labour and birth.
The intervention: midwifery continuity of care
Midwifery continuity of care allows women to develop a
relationship with the same caregivers throughout preg-
nancy, birth, and the postnatal period. Women have a
midwife caring for them during labour and birth whom
they have met before and feel that they know, and this
trusting relationship increases their confidence [26,27].
Women with a previous CS are often included in trials
of midwifery continuity of care although they have not
been specifically studied or targeted.
Midwifery continuity of care per se has been widely
studied. A systematic review in the Cochrane Library
examining midwifery continuity of care included 11 trials
(12,276 women). Women who had midwife-led models of
care were less likely to use regional analgesia (RR 0.81, 95%
CI 0.73–0.91) or have an instrumental birth (RR 0.86, 95%
CI 0.78–0.96), and were more likely not to use intrapartum
analgesia/anaesthesia (RR 1.16, 95% CI 1.05–1.29), ex-
perience spontaneous vaginal birth (RR 1.04, 95% CI
1.02–1.06), feel in control during labour and childbirth
(RR 1.74, 95% CI 1.32–2.30), and initiate breastfeeding
(RR 1.35, 95% CI 1.03–1.76) [22]. Three trials have shown
that midwifery continuity of care significantly reduced the
CS rate: one small trial in Canada [28] and two in Australia,
the most recent being published in 2012 [29,30].
In preliminary work for this trial, we reviewed the
outcomes of a midwifery continuity of care program at
one NSW hospital and compared the VBAC rate in the
program with the rates in the area health service (AHS)
in which the hospital is situated. The rate of attempted
VBAC was 62.5% in the midwifery continuity of care
program compared with 27% for the AHS and the vagi-
nal birth rate was considerably higher in the program
(76% and 54%, respectively). There was no increase in
adverse outcomes for mothers or babies, although the
total numbers in this evaluation were small (n = 377)
(unpublished data). These data, although from a small
number of women, provide some evidence to support the
hypothesis to be tested in this trial, that is, that midwifery
continuity of care will increase the proportion of women
who attempt VBAC, increasing the overall rate of vaginal
birth and reducing the CS rate.
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The study uses a two arm, un-blinded randomised con-
trolled design, to compare the outcomes for women
who had midwifery continuity of care compared with
those who had standard maternity care.
Aim and objectives
The primary aim is to determine whether midwifery con-
tinuity of care for women with a previous CS increases the
proportion of women who attempt vaginal birth in their
current pregnancy. The primary hypothesis is that women
with a previous CS, who are eligible for a vaginal birth and
receive midwifery continuity of care, will be 50% more
likely to choose to attempt a vaginal birth in their current
pregnancy than similar women receiving standard care.
The secondary aims are to determine whether midwifery
continuity of care increases the proportion of women
experiencing a vaginal birth, and affects neonatal health or
the emotional outcomes for women; and to explore the
differences in women’s experiences of care and the de-
cision making processes between the groups.
Study population
All eligible women booking maternity care at two study
sites in Australia will be invited to participate.
Sample size
Our study of VBAC in NSW [17] showed that only 35%
of women who are eligible for a vaginal birth following
one previous CS attempted VBAC. The trial is designed
to detect a clinically significant increase in the primary
outcome, attempted VBAC, from 35% to 52.5%. In order
to detect this difference 274 women will be required,
providing 80% power with α = 0.05. To allow for a 15%
loss to follow-up, a total of 332 women will be required,
166 in each group. This sample size will also be sufficient
to demonstrate a significant improvement in VBAC success
rates from 53% to 70.5% (n = 262).
The data informing the sample size calculations are
drawn from a published cross-sectional study using
population-based data from NSW [17,31] and descriptive
data from the Obstetrix perinatal database at one of our
study sites. Currently, midwives at this hospital providing
continuity of care to women eligible for a VBAC are
achieving attempt rates of 62.5% and success rates of 76%.
Control and intervention groups
Intervention
Midwifery continuity of care (CofC) Women allocated
to the intervention group will receive midwifery continuity
of care from a small group of midwives.[27] The midwives
provide care during the antenatal, labour and birth,
and postnatal periods (to two weeks postnatal). Midwives
will adhere to The National Midwifery Guidelines forConsultation & Referral [32]. All women will have an
appointment with an obstetric consultant during pregnancy
(to re-assess VBAC suitability and discuss the birth plan). If
a woman develops complications during pregnancy and
requires additional care, she will continue with the midwif-
ery continuity of care model while also attending obstetric
or other consultations (this is the same for both groups).
Labour and birth care will be provided at the hospital’s
birth unit/labour ward and postnatal care will be provided
in hospital or the woman’s own home following discharge
from hospital.
Control
Standard midwifery care Women allocated to the control
group will receive the current model of public maternity
care at the two study sites. Antenatal care is provided by
antenatal staff (midwives and obstetricians). Staff in the
Birth Unit provides labour and birth care and midwives in
the postnatal ward provide postnatal care. Women are
also offered midwifery visits at home following discharge
from hospital (4–48 hours after a vaginal birth). All these
care providers are different people.
Inclusion criteria
 Most recent birth was by lower-segment CS
 No more than one previous CS
 Considered low risk, other than a history of one
previous CS
 No other previous uterine incision
 No previous uterine rupture
 No contraindications for vaginal birth at the time of
enrolment
 English proficiency (spoken and written)
 Public patient
 No known preference for a certain model of care, such
as: GP-shared care or midwifery continuity of care
Exclusion criteria
 Women who reside outside the hospital postnatal
home-visiting zone
 Women who specifically request an ERCS at
booking in
 Women with BMI > 35
Trial recruitment
Women telephone the booking office to book for maternity
care and receive an appointment for their first/booking-in
visit. The women will be initially screened by the booking
clerk for eligibility into the trial according to the eligibility
criteria. An information pack about the study is posted to
all eligible women. At the first/booking-in visit, the research
assistant (RA) approaches each eligible woman and asks if
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in participating. If the woman agrees, the consent form is
signed and the woman is registered as a trial participant
and the remote telephone allocation service at the univer-
sity is contacted for random allocation.
Group allocation
Randomisation will be on a 1:1 basis. Allocation conceal-
ment will be assured by using a remote telephone allocation
service through the university research department. The
RA will telephone the university to provide the woman’s
initials, medical record number and date of birth. The clerk
at the university campus will allocate women based on a
randomization schedule developed independently from the
RA. The midwife will be informed of the group to which
the woman has been allocated and will receive her study
number, which will be recorded in the Trial Register and
Log Book. If allocated to standard care, the woman will
be advised of her next clinic appointment. If allocated
to midwifery continuity of care, she will be advised that




The majority of clinical data required for the study are
routinely collected and available in hospital records. The
RA will collect these data and 5% of the records will be






 Previous pregnancy outcomes
 Socio-economic status (derived from postcode,
marital and employment status,)
 Past medical, surgical and obstetric risk factors
Pregnancy
 Complications during pregnancy
 Planned mode of birth prior to labour/CS
Labour and birth
 Syntocinon augmentation
 Artificial rupture of membranes
 Immersion in water for pain relief
 Epidural or spinal anaesthesia
 General anaesthetic
 Mode of birth Uterine rupture or scar dehiscence
 Major postpartum haemorrhage > 1000 mL and/or
requiring operative procedure and/or blood
transfusion
 Length of hospital stay
 Readmission Admission to ICU/HDU
 Maternal death (within 42 days)
Neonatal
 Apgar score < 7 at 5 min
 Admissions to neonatal unit within 48 hours of
birth for at least 48 hours with feeding difficulties or
respiratory distress
 Readmission to hospital
 Breastfeeding within 1 hour of birth
 Skin to skin contact within one hour of birth
 Mode of feeding at 6 weeks
 Stillbirth and neonatal death (within first 28 days)
Women’s experiences
Two questionnaires have been developed for administra-
tion at 36 weeks gestation (during pregnancy) and at 6–
8 weeks post-partum (after the birth). These will enable
women to report on their experiences with the model of
care, their planned mode of birth (VBAC or CS) and the
factors influencing the mode of birth choice. Distress
and anxiety will be assessed using the Depression Anxiety
Stress Scale (DASS 21) [33] and Edinburgh Postnatal
Depression Scale (EDPS) [34]. Decisional conflict, know-
ledge, and anxiety will be assessed using measures from a
previous Australian study [24].
The postnatal questionnaire includes questions about
their labour and birth experiences and satisfaction with
their decisions. With permission, we have adapted ques-
tions about the experience of care from surveys used to
assess satisfaction in the COSMOS Study which exam-
ined the impact of caseload midwifery care on low risk
women in Melbourne, Australia [29].
Both questionnaires were piloted with pregnant and
postpartum women. Completion of each took approxi-
mately 20 minutes and they were reported to be under-
standable to the average adult reader.
Administration of questionnaires
The questionnaires have been professionally designed and
printed. The women will be posted the questionnaires
with a self-addressed envelope with a reply-paid stamp.
The RA will contact participants to inform them that the
questionnaire has been posted. The questionnaires will
be linked to the participant by attaching the study code
(documented in the log book) to the inside of the front
cover of each booklet.
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The analysis will be by ‘intention to treat’, including
withdrawals and losses to follow-up. Randomisation should
ensure that the groups are similar or equivalent in their
baseline characteristics; additional multivariate analysis will
be used if baseline differences are noted between the two
groups. The relative risks (with 95% confidence intervals)
of the primary outcomes will be calculated. Secondary
outcome measures of categorical data will be analysed
with χ2 tests and continuous data will be analysed
with t-tests (for normally distributed data). Ranked or
Likert-scale data will be analysed using cumulative
odds ratios. Logistic regression and multiple linear
regressions will be used if necessary to adjust for any
other confounding variables.
It is not possible to blind participants to the model of
care they receive, but outcome assessments will be blinded.
Interim analysis
A multidisciplinary data-monitoring group has appointed
at the outset of the study to monitor the safety of the trial
particularly examining differences between the groups that
may be larger than expected and assessing any serious ad-
verse effects that may occur. After 50% of the women have
enrolled, a difference of at least three standard deviations
in the interim analysis of a major endpoint will be needed
to justify stopping the trial.
Confidentiality and data security
All paperwork, documentation, internet and audiotaped
data will be treated with confidentiality. The log books
required on–site are kept in the office of the booking
clerk. This office is staffed during business hours, and is
only used by one staff member. The door is locked when
the room is empty. Hard copies of client details and study
matters are kept in a filing cabinet within the locked area
at the university.
Ethical aspects
Human Research Ethics Committee (HREC) approval
for all current sites has been provided by the North Sydney
Central Coast HREC, according to the single site HREC
approval for multicentre clinical trials guidelines. Research
governance approval has been provided by the Research
Governance Office at each site.
Data safety and monitoring
A Data and Adverse Event Monitoring Committee will
assess the safety and serious adverse events and will be
blinded to the assigned group. Serious adverse events
will be given a Severity Assessment Code consistent with
incident monitoring in NSW [35] and reviewed by the
Committee. Any perinatal deaths will be analysed to
determine whether the model of care contributed.Interruption of the study
The CIs may terminate this study prematurely, either in
its entirety or either of the sites, for reasonable causes
(e.g. unsatisfactory enrolment with respect to quantity or
quality, inaccurate or incomplete data collection, falsifica-
tion of records, failure to adhere to protocol). If this occurs,
the site investigator will provide written notice to the CIs of
the intended termination.
Discussion
One of the greatest contributors to the overall CS rate is
women having elective repeat CS. In this study, we will test
the effects of midwifery continuity of care (where women
have the same midwives through pregnancy and during
labour and birth) on rates of vaginal birth and other
outcomes in women with a prior CS. This will be the first
Australian and international randomised controlled trial of
midwifery continuity of care that focuses on women who
have had a previous CS. High level evidence on midwifery
continuity of care shows that these models increase women’s
sense of control over decision making [22] hence the link in
our hypothesis – that is, increased control will impact on de-
cision making and increase rates of attempted vaginal birth.
Pregnancy, birthing and early parenthood are profoundly
important life experiences that directly affect almost
300,000 families in Australia each year. An increasing
CS rate is of national and international concern. The
Editor of the prestigious journal Birth wrote in 2007
“reducing the caesarean birth rate worldwide is a complex
and difficult task that must be tackled on many fronts using
multiple strategies” [36]. A key finding of the Maternity
Services Review in Australia was that the CS rate was higher
than many similar countries and this highlighted the need
for more research in this area [2]. The Australian National
Maternity Services Plan [37] has also drawn attention to
the fact that the high rates of caesarean section are often
compounded by a lack of support for vaginal births after
caesarean section providing preliminary evidence that
midwifery continuity of care will indeed increase VBAC.
This will be the first national and international trial that
has tested midwifery continuity of care as an intervention to
increase vaginal birth rates in women who have had a previ-
ous CS. Although a number of studies have focused on
interventions that improve the rates of attempted and/or
successful VBAC, they have not been able to demonstrate
their effectiveness. This study will provide this evidence
that can be used to improve maternal outcomes while
maintaining the safety of Australian mothers and babies.
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